Feature Channels: Pharmaceuticals

Filters close
Newswise: St. Jude approach prevents drug resistance and toxicity
Released: 28-Feb-2023 11:15 AM EST
St. Jude approach prevents drug resistance and toxicity
St. Jude Children's Research Hospital

Scientists at St. Jude Children’s Research Hospital showed an effective method to avoid activating a major cellular detoxification receptor to overcome drug resistance and toxicity.

27-Feb-2023 10:25 AM EST
Study Finds 1-in-5 Patients at High Risk of Cardiovascular Disease Refuse Statin Therapy
Brigham and Women’s Hospital

Heart disease is the leading cause of death worldwide, killing someone in the United States every 34 seconds, according to the Centers for Disease Control and Prevention. A new study by investigators from Brigham and Women’s Hospital, a founding member of the Mass General Brigham healthcare system, conducted the first population-based study on patients’ nonacceptance of statin therapy recommendations.

Released: 27-Feb-2023 2:55 PM EST
National Organization of Rare Disorders (NORD) Announces 2023 Rare Impact Award Honorees
National Organization for Rare Disorders (NORD)

National Organization for Rare Disorders (NORD®) Founder and past President Abbey S. Meyers, PhD, former U.S. Rep. Jaime Herrera Beutler of Washington State, New York Yankees centerfielder Bernie Williams, and pioneer clinical geneticist, Dr.Ada Hamosh, headline a group of rare disease champions who will be honored for their outstanding contributions to the rare disease community at NORD's 2023 Rare Impact Awards (RIA).

Newswise: TCT 2023 Master Operator Award to Be Presented to William L. Lombardi, MD
Released: 27-Feb-2023 11:05 AM EST
TCT 2023 Master Operator Award to Be Presented to William L. Lombardi, MD
Cardiovascular Research Foundation (CRF)

The TCT Geoffrey O. Hartzler Master Operator Award will be presented to William L. Lombardi, MD during Transcatheter Cardiovascular Therapeutics (TCT), the annual scientific symposium of the Cardiovascular Research Foundation (CRF). TCT will take place October 23-26, 2023, in San Francisco at the Moscone Center. The award is given each year to a physician who has advanced the field of interventional cardiovascular medicine through technical excellence and leadership.

Newswise: Department of Defense Grants University of Miami Researcher $3.25 Million to Study Male Infertility after Spinal Cord Injury
Released: 27-Feb-2023 7:05 AM EST
Department of Defense Grants University of Miami Researcher $3.25 Million to Study Male Infertility after Spinal Cord Injury
University of Miami Health System, Miller School of Medicine

Emad Ibrahim, M.D., director of the Male Fertility Research Program at The Miami Project to Cure Paralysis and the clinical andrology lab at the Desai Sethi Urology Institute at the University of Miami Miller School of Medicine, has been awarded a $3.25 million grant by the Department of Defense for a four-year study on the use of an oral medication to treat an infertility issue that affects most men with spinal cord injury.

18-Feb-2023 10:05 AM EST
Black People Less Likely to Receive Dementia-Related Medications
American Academy of Neurology (AAN)

Black people are receiving medications for dementia less often than white people, according to a preliminary study released today, February 26, 2023, that will be presented at the American Academy of Neurology’s 75th Annual Meeting being held in person in Boston and live online from April 22-27, 2023.

Newswise: Markey Cancer Center study shows potential for new radiopharmaceutical cancer treatment
Released: 24-Feb-2023 1:25 PM EST
Markey Cancer Center study shows potential for new radiopharmaceutical cancer treatment
University of Kentucky

A recent University of Kentucky Markey Cancer Center study suggests a new radiopharmaceutical compound may be a viable treatment option for patients with advanced cervical cancer.

Released: 23-Feb-2023 11:00 AM EST
Mystical and insightful psychedelic experience may improve mental health
Ohio State University

A more mystical and insightful psychedelic drug experience may be linked to an enduring reduction in anxiety and depression symptoms, according to a new study.

17-Feb-2023 12:55 PM EST
Study: People Who Regularly Use Laxatives May Have an Increased Risk of Dementia
American Academy of Neurology (AAN)

People who regularly use laxatives, a common treatment for constipation, may have more than a 50% increased risk of developing dementia than people who do not use laxatives, according to a study published in the February 22, 2023, online issue of Neurology®, the medical journal of the American Academy of Neurology. Researchers also found people who used only osmotic laxatives, a type of laxative that attracts water to the colon to soften stool, had an even greater risk. Other types of laxatives are bulk-forming, stool-softening, and stimulating. The study does not prove that laxatives cause dementia. It only shows an association.

Released: 21-Feb-2023 7:35 PM EST
Pill for skin disease also curbs excessive drinking
Oregon Health & Science University

Researchers from Oregon Health & Science University and institutions across the country have identified a pill used to treat a common skin disease as an “incredibly promising” treatment for alcohol use disorder.

Released: 21-Feb-2023 2:05 PM EST
A New Catalyst For Recycling Plastic, New Antioxidants Found In Meat, And Other Chemical Research News
Newswise

Below are some of the latest articles that have been added to the Chemistry news channel on Newswise.

Newswise: Lo Que Debes Saber Acerca del Medicamento Recientemente Aprobado Contra el Alzheimer
Released: 21-Feb-2023 1:25 PM EST
Lo Que Debes Saber Acerca del Medicamento Recientemente Aprobado Contra el Alzheimer
Cedars-Sinai

Leqembi, Recientemente Aprobado por la FDA, Muestra un Beneficio Potencial para los Pacientes con Enfermedad en Etapa Temprana, pero la Disponibilidad Llevará tiempo, Comenta Experta de Cedars-Sinai

Released: 21-Feb-2023 11:35 AM EST
Pain management pathway reduces use of opioids after urethral repair surgery
Wolters Kluwer Health: Lippincott

For men undergoing surgery to repair scarring in the urethra (urethroplasty), a new approach to pain management can reduce the need for strong opioid drugs without compromising pain control, reports a study in Urology Practice®, an Official Journal of the American Urological Association (AUA). The journal is published in the Lippincott portfolio by Wolters Kluwer.

Newswise:Video Embedded rna-rescue-challenge-invites-players-to-solve-puzzles-and-advance-rna-therapeutics
VIDEO
Released: 21-Feb-2023 11:35 AM EST
RNA Rescue challenge invites players to solve puzzles and advance RNA therapeutics
University of California, Santa Cruz

Researchers at UC Santa Cruz working to develop novel RNA-based medicines are teaming up with a new group of collaborators—players of the online game Eterna. The

Released: 20-Feb-2023 10:05 PM EST
Doxycycline does not prevent STIs among cisgender women
Hennepin Healthcare Research Institute

Researchers from the University of Washington (UW), Kenya Medical Research Institute (KEMRI), and Hennepin Healthcare Research Institute (HHRI) announced results at CROI from a clinical trial demonstrating that doxycycline taken after sex does not prevent bacterial sexually transmitted infections (STIs) – chlamydia or gonorrhea – among cisgender women.

Released: 20-Feb-2023 10:05 PM EST
No safety concerns seen with use of dapivirine vaginal ring during third trimester of pregnancy, according to interim results of DELIVER study
Microbicide Trials Network, University of Pittsburgh

A vaginal ring containing the antiretroviral drug dapivirine posed no safety concerns when used in the third trimester of pregnancy, according to results to date from the first study of the dapivirine ring during pregnancy and one of only a few studies of an HIV prevention product in pregnant cisgender women.

Newswise: Neuroscience Tool’s Structure May Lead to Next Gen Versions
Released: 20-Feb-2023 5:05 PM EST
Neuroscience Tool’s Structure May Lead to Next Gen Versions
University of Maryland School of Medicine

A University of Maryland School of Medicine researcher and his colleagues at the University of North Carolina Chapel Hill have unveiled the structure of DREADDs (Designer Receptors Activated by Designer Drugs) that will pave the way for creating the next generation of these tools. This step ultimately will bring them closer to an elusive goal — understanding the underpinnings of brain disorders and develop new treatments.

   
Newswise: Researchers Uncover Mechanisms of Brexanolone and the Role of Inflammation in Post-partum Depression
Released: 20-Feb-2023 2:45 PM EST
Researchers Uncover Mechanisms of Brexanolone and the Role of Inflammation in Post-partum Depression
University of North Carolina Health Care System

Brexanolone, an IV infusion comprised of a derivative of progesterone, was approved by the U.S. Food and Drug Administration for the treatment of PPD in 2019. The fast-acting medication significantly reduces depression symptoms and provides effects for up to 90 days. However, exactly how the drug provides these therapeutic effects has remained a mystery – until now.

Newswise: Using light to switch drugs on and off
Released: 20-Feb-2023 1:30 PM EST
Using light to switch drugs on and off
Paul Scherrer Institute

Scientists at the Paul Scherrer Institute PSI have used the Swiss X-ray free-electron laser SwissFEL and the Swiss Light Source SLS to make a film that could give a decisive boost to developing a new type of drug.

Newswise: Receptor location matters for psychedelic drug effects
Released: 16-Feb-2023 4:55 PM EST
Receptor location matters for psychedelic drug effects
University of California, Davis

Location, location, location is the key for psychedelic drugs that could treat mental illness by rapidly rebuilding connections between nerve cells.



close
3.33801